The latest immunotherapy news and developments
In preclinical studies, researchers found that priming the immune system with a Treg-expanding therapy before…
Cervical cancer, which affects the reproductive tract, is one of the most common cancers in…
Chimeric Antigen Receptor (CAR) T cell therapies have revolutionised cancer treatment, but so far, their…
Immune checkpoint therapy, a key strategy in tumour immunotherapy, has demonstrated significant efficacy against solid…
Hepatocellular carcinoma (HCC), the most common primary liver cancer, poses a global health threat with…
For a little over two decades, chimaeric antigen receptor (CAR) T cell therapy has emerged…
In a new study, researchers created a model for cutaneous squamous cell carcinoma, a type…
Cancer Centre at Illinois (CCIL), USA, member Hua Wang has published new research detailing a…
Scientists at the Fralin Biomedical Research Institute at VTC and their collaborators are exploring emerging trends in cancer…
Combining an epigenetic therapy with an anti-PD-1 antibody, which uses the body’s natural response to…